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The American University in Cairo
ABSTRACT
Isolation, Propagation and Characterization of Mouse Testis-Derived Mesenchymal
Stromal Cells
By: Mai Omar Abdul Rahman
Under the supervision of: Dr. Asma Amleh
Mesenchymal Stromal/Stem Cells (MSCs) are considered promising tools for
regenerative therapy. MSCs are multipotent cells that have been successfully isolated
from different species and tissues. Although few studies have reported the isolation of
MSCs from the testis, there are no reports on their isolation from the mouse, despite its
close genetic similarity to humans. Since the testis is a heterogeneous population,
enriching for MSCs will aid in the generation of homogeneous populations from early
passages. The aim of our work was to utilize the mouse model for the isolation,
propagation and subsequent characterization of testis-derived MSCs (tMSCs).
To achieve this aim, we harvested testes from 12 male mice and generated single-cell
suspensions using a two-step enzymatic digestion technique. Next, we employed a
laminin-based technique to enrich for MSCs. The isolated cells were cultured in vitro and
growth kinetics was assessed by calculating the Population Doubling Time (PDT). To
characterize the isolated cells, Reverse Transcription-Polymerase Chain Reaction (RTPCR) was performed on MSC markers (CD44, CD73 and CD29), hematopoietic cell
marker (CD45), the pluripotency markers Nanog and Oct4 and the germ cell marker
Vasa. Also, the percentages of cells expressing CD44 and CD45 were assessed by
immunophenotyping using flow cytometry.
Successful cultures of tMSCs were established, and the early passages exhibited high
proliferation patterns with average PDT 47.7 hours. RT-PCR data, confirmed by
Immunophenotyping, revealed the positive expression of CD44 and the negative
expression of CD45 in tMSCs. In addition, tMSCs expressed CD73 and CD29 at the
transcript level. Loss of the fibroblast-like morphology in late passages together with the
increase in PDT and the decrease in expression levels of CD73 and CD29 suggested that
tMSCs started to undergo phenotypic divergence. As for the pluripotency markers,
tMSCs were found to express Nanog but not Oct4. Interestingly, a significant variation in
the expression patterns of different Nanog variants was observed in the isolated cells. The
lack of Vasa expression suggested that tMSCs are, most likely, not of germ cell origin.
To our knowledge, this is the first study to report the isolation of Mesenchymal Stromal
Cells from the mouse testis. Based on our findings, tMSCs possess characteristics and
marker profiles similar to that of MSCs, which makes them a potentially valuable tool in
cell therapy.
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1. Literature Review
1.1.Stem Cells
Stem cells are unspecialized cell types which have the intrinsic capability of selfrenewal to generate more stem cells and the ability to differentiate into other more
specialized cell types with specific functions (Verfaillie, 2009). Self renewal can be
achieved through symmetrical or asymmetrical cell divisions; symmetrical cell division
occurs when the cell divides giving rise to two identical stem cells of equal differentiation
capabilities similar to the parent cell. On the other hand, asymmetrical division occurs
more dominantly in adult tissues where a stem cell divides into two daughter cells; one
identical to the mother stem cells and one committed to a particular differentiation
pathway. This kind of division replenishes the pool of stem cells while producing more
differentiated tissue-specific cells (Shenghui et al., 2009).
There are different types of stem cells in different tissues and organs and each
type of stem cells has its unique properties. Stem cells can be classified either according
to their differentiation potential or their source (Can, 2008). Stem cells are classified
according to their differentiation capacities into four types; totipotent, pluripotent,
multipotent and unipotent. While totipotent cells are capable of generating the embryo
proper and supporting its implantation, pluripotent cells produce the embryo but are not
competent for establishing implantation (Mitalipov and Wolf, 2009). On the other hand,
multipotent stem cells are restricted in their development to certain subtypes of cell
lineages. Mesenchymal multipotent stem cells (MSCs) can differentiate into cells of the
mesodermal origin (Zuk et al., 2001). Finally, unipotent stem cells develop into one type
of specialized cells like spermatogonial stem cells generating sperms (Ko et al., 2009).
Stem cells are also classified according the developmental stage or the source
from which they were isolated into two major types; embryonic stem cells (ESCs) and
adult stem cells. ESCs are pluripotent in nature and they can be derived from the inner
cell mass (ICM) of early embryos. Their pluripotent properties make them capable of
differentiating into any cell type in the body (Puri and Nagy, 2012). Adult stem cells are
the type of stem cells present in adult tissues of the body and they possess different
properties and potentials. Adult stem cells are committed to tissue repair following injury
1

and tissue regeneration during normal cellular turnover (Wei et al., 2013). To date,
multiple types of adult stem cells have been isolated. Bone marrow mesenchymal
stromal/stem cells are the most common type of adult stem cells, there are also brain stem
cells, skeletal muscle stem cells, liver stem cells and many others (Passier and
Mummery, 2003).

1.2.Mesenchymal Stromal /Stem Cells
Mesenchymal Stem cells are unique cell types which constitute a rare population
in the stem cell niche of adult tissues. They have captured the interest of biomedical
researchers over the past 10-15 years because of their unequivocal properties. MSC, are
referred to as “mesenchymal” because of their ability to differentiate into cells of the
mesoderm which stimulated intensive investigation into their role in tissue regeneration
(Keating, 2012). They were first described by Friedenstein et al. as a subpopulation of
the bone marrow which possesses osteogenic potentiality (Friedenstein et al., 1968).
Many studies emerged after Friedenstein’s work reporting the isolation of MSCs from
different tissues; they were successfully isolated from adipose tissue (Zuk et al., 2002),
umbilical cord blood (Erices et al., 2000), dental pulp (Gronthos et al., 2000), synovial
membrane (De Bari et al., 2001) and even from breast milk (Patki et al., 2010).
Although “Mesenchymal Stem Cells” is a commonly utilized terminology to
define these cell types, “Mesenchymal Stromal Cells” is considered a more appropriate
one since these cells comprise a heterogeneous population of cells which contain stem
cells together with other cell types (Horwitz et al., 2005).

1.3.Characteristics of MSCs
In 2006, the International Society for Cellular Therapy proposed a set of
minimum criteria for human MSCs. These criteria included plastic adherence and in vitro
trilineage differentiation into adipogenic, chondrogenic, and osteogenic cells. Additional
requirements included cell surface expression of Cluster of Differentiation markers;
CD105 (endoglin, SH2), CD73 (ecto-5′-nucleotidase), and CD90 (Thy1) and the absence
of the hematopoietic markers, CD45, CD19 or CD79, CD14 or CD11b, and HLA-DR
(Dominici et al., 2006). However, these criteria were found constraining as different
2

populations of MSCs have been isolated from different tissues each of which possesses
its own unique properties (Keating, 2012). Also, the proposed criteria are not entirely
valid across different species. In mouse models, MSCs exhibit different marker
expression profiles and culture characteristics not only from the human MSCs, but also
between strains (Peister et al., 2004; Sung et al., 2008).

1.3.1. Expansion patterns of MSCs in vitro
Mesenchymal stem cells are spindle-shaped fibroblast-like cells which are
capable of forming colonies of fibroblasts (Colony Forming Unit Fibroblasts or CFU-F)
(Friedenstein et al., 1970; Li et al., 2005). To utilize MSCs in clinical settings, it is
important to study the expansion patterns of these cells in vitro in order to obtain
sufficient quantities for therapeutic uses. The cell cycle is an ordered and highly
organized process that is committed to the precise duplication and transmission of genetic
information among different cell generations (Israels and Israels, 2001). Primary
mammalian somatic cells have the capacity to expand in vitro for an estimated 50
population doublings, after which the cultures stop expanding, this phenomenon is
termed Hayflick’s limit or more commonly known as “replicative senescence” (Hayflick
and Moorhead, 1961). Although stem cells have the capacity to regenerate themselves
continuously in the body, they show time-limited proliferation and differentiation
potential in an ex-vivo setting. They are subject to the Hayflick limit (DiGirolamo et al.,
1999; Jiang et al., 2002a; Izadpanah et al., 2005). It was proposed that early passages
MSCs display a population doubling time (PDT) of 24–48 hours (hr). However, this PDT
is variable depending on the culture media and passage number (Safford and Rice, 2005;
Izadpanah et al., 2006). Actually, the duration of the cell cycle increases significantly
with prolonged cultures to as long as 150 hr. in MSC cultures of human and non human
primate MSCs (Bonab et al., 2006).
Mesenchymal stem cell show highly variable culturing patterns among different
populations. This variability has posed a struggle to compare results from different
groups. The variability has been mainly attributed to the culture parameters in terms of
the number of passages, the culture media, cell confluence and even plastic surface
quality could influence the behavior of MSCs in culture (Barrilleaux et al., 2006).
3

Historically, the culture medium used to grow MSCs was simple and composed of
basal culture medium (i.e. Dulbecco’s Modified Eagle’s Medium (DMEM) or Minimum
Essential Medium alpha (MEM-α)) supplemented with fetal bovine serum (FBS) with or
without additional growth factors (i.e. basic fibroblast growth factor (bFGF)). Despite the
fact that the serum containing formulations provided successful and robust expansion of
MSC, there is an increased trend towards using low or serum free culture media because
of several problems associated with the use of FBS. Serum holds the risk of
contamination with pathogens, not to mention the significant lot-to-lot variability that
could infer variability in experimental results like differentiation, proliferation,
proteomics and genomics (Spees et al., 2004; Dimarakis and Levicar, 2006; Mannello
and Tonti, 2007; Chase et al., 2010). Also, several growth factors and cytokines are
reported to be used in culturing MSCs and maintaining its “stemness” state. Leukemia
inhibitory factor and fibroblast growth factors (FGFs) are among the different important
factors which have drawn particular interest because of their proven roles in either
maintaining undifferentiated mesenchymal tissue or in the self renewal process of other
types of stem cells (Metcalf, 2003; Zaragosi et al., 2006).
Many studies report that human MSCs derived from the marrow undergo
senescence during prolonged culturing. Signs of senescence usually involve
morphological changes, decreased differentiation potential and shortening of the mean
telomere length. The mean telomere length plays an important role in cell senescence as a
result of decreased telomerase activity (Bonab et al., 2006). It has previously been
reported that cultures of MSCs derived from the bone marrow and adipose tissue
underwent morphological alteration upon senescence associated with a decline in
multipotency potential and a marked decrease in telomerase activity, these features
seemed to occur progressively with multiple passaging (Izadpanah et al., 2005).

1.3.2. Surface markers of mesenchymal stem cells
Mesenchymal stem cells are usually identified phenotypically by the concomitant
expression of certain cell surface markers. Although MSCs express a number of markers,
unfortunately, none of them are specific to MSCs. It is generally agreed that there is a
panel of negative markers which adult human MSCs do not express; the hematopoietic
4

markers CD45 (a marker for all hematopoietic cells), CD34 (Hematopoietic progenitor
cell antigen), CD117 (a hematopoietic stem/progenitor cell marker), CD14, or CD11b (an
immune cell marker). Also, they were found to lack the expression of the costimulatory
molecules CD80 (B lymphocyte activation antigen), CD86 (T-lymphocyte activation
antigen), CD40 (Tumor necrosis factor receptor superfamily member 5), the adhesion
molecules CD31 (platelet/endothelial cell adhesion molecule [PECAM]-1), CD18
(leukocyte function-associated antigen-1 [LFA-1]) and CD56 (neuronal cell adhesion
molecule-1). The lack of expression of these markers confirms the undifferentiated state
of MSCs. On the other hand, there is no consensus regarding definitive positive markers
for MSCs. A myriad of markers has been reported by different groups depending on the
tissue of origin or on the species. However, it was found that MSCs can express CD44,
CD29 (Integrin beta-1), CD105 (Endoglin), CD73 (ecto-5'-nucleotidase), CD90 (Thy-1),
CD71 (Transferrin receptor protein 1 or TfR1), and Stro-1 as well as the adhesion
molecules CD106 (vascular cell adhesion molecule [VCAM]-1) and CD166 (activated
leukocyte cell adhesion molecule [ALCAM]) (Conget and Minguell, 1999; Pittenger et
al., 1999; Sordi et al., 2005).
CD105 is the TGF-beta receptor III, which is reported to have a potential role in
TGF-beta signaling during MSC chondrogenic differentiation (Barry et al., 1999). CD73
or ecto-5-nucleotidase is known to be involved in bone marrow stromal interactions,
MSC migration, potentially and MSC modulation of adaptive immunity (Barry et al.,
2001; Eckle et al., 2007; Ode et al., 2011). The function of the CD90 (Thy1 antigen) in
MSC regulation is not fully elucidated. It has been postulated to mediate cell-cell
interactions and participate in the adhesion of polymorphonuclear monocytes, leukocytes
to microvascular endothelial cells and fibroblasts (Saalbach et al., 2000; Haeryfar and
Hoskin, 2004)
As for CD44, it is a multifunctional glycoprotein which is expressed in all the
stromal cells. It commonly regulates cell–cell adhesion and migration. Its most noted
ligands include hyaluronan and osteopontin. It has been recently proposed to mark
several types of cancer stem cells. Its numerous other functions include roles in matrix
assembly and apoptosis resistance (Spaeth et al., 2013).

5

There are many reports on the significant variability in the expression of many of
the markers mentioned above due to variation in either tissue source, the method of
isolation or culture and species differences (Baddoo et al., 2003; Javazon et al., 2004).
MSCs from different species do not always have the same expression pattern of surface
molecules as those on human cells; for example, although human and rat MSCs are
known to be devoid of the endothelial cell marker CD31 and the hematopoietic marker
CD45, there are contradicting reports with regards to CD34. Variable expression of CD34
has been reported on murine MSCs (Peister et al., 2004). As for CD90, a strong pattern
of expression was found in almost all the species tested but was found absent on MSCs in
goats and sheep. Also, CD90 expression was postulated to be more restricted to humans
when compared to mice (Boxall and Jones, 2012). In fact, CD90 was found to have
different patterns among different strains of mice due to the variable expression of two
alternative CD90 antigens (CD90.1/Thy1.1 or CD90.2/Thy1.2), which only differ by one
amino acid (Rege and Hagood, 2006).

1.3.3. Multipotenty potential of MSCs
The ability to differentiate along several mesenchymal cell lineages is a unique
feature and fundamental property of MSCs. MSC potency extends beyond the
conventional mesodermal lineages (osteoblasts, adipocytes and chondrocytes) and
includes differentiation into liver, muscle, kidney, neural, skin, and cardiac cells (Arthur
et al., 2009). However, the differentiation of MSCs varies significantly and depends on
the tissue source. Also, in vitro propagation leads to a substantial loss of multipotentiality as a result of cellular senescence. Studying the multipotency of MSCs has
allowed researchers to understand more about the differentiation pathways of various
lineages for tissue engineering and therapeutic purposes. For an effective clinical
application, the ability to change biological effectors to either maintain or prevent a
differentiation program is necessary. However, the identification of specific signaling
networks and regulatory genes that regulate MSC differentiation to different lineages
remains a challenge (Kolf et al., 2007; Via et al., 2012).
Chondrogenesis is a complicated and well organized event which requires
commitment of MSCs, followed by their differentiation into chondrocytes (Akiyama,
6

2008). In vitro differentiation of MSCs into a chondrogenic lineage has been attributed to
many factors; co-culture with cartilage through exposure to growth factors, or via the
overexpression of specific genes such as Sox9 which has been postulated to promote
chondrocytic differentiation. In fact, inducing ectopic expression of Sox9 in mice
upregulates type 2 collagen (Bell et al., 1997; Tsuchiya et al., 2003). TGFβ is another
key molecule implicated to have a role in chondrogenic differentiation. Interestingly, the
low chondrogenic potential in adipose tissue-derived MSCs (AT-MSCs) was overcome
by inducing the overexpression of TGFβ receptor1 (Hennig et al., 2007). Needless to say,
the ability to promote and control chondrogenic differentiation in MSCs has significant
clinical application for treating conditions such as intervertebral disc degeneration
(Richardson et al., 2006).
The generation of osteoblasts by mesenchymal stem cells has been well
documented. Several molecules have been implicated in the control of osteogenic
differentiation; Wnts are postulated to be strong modulatory elements where their high
endogenous levels are correlated with enhanced osteogenesis (Gaspar and Fodde,
2004). Also, a regulatory network of Bmps, Runx2 and TNFα was found to regulate
osteogenesis (Kaneki et al., 2006). These different regulatory elements could serve as
potential targets for MSC-based bone tissue engineering.
MSC capacity to generate adipocytes has been extensively studied. PPAR-γ is
among the key molecules thought to regulate the function of many adipocyte specific
genes (Rosen and Spiegelman, 2000). Adipogenesis can be induced either through the
exposure to exogenous factors or by culturing MSCs in adipogenic media containing
insulin and dexamethasone. Molecules known to regulate adipogenesis could serve as
possible candidates for the treatment of obesity (Farmer, 2005; Yin et al., 2010).
The differentiation potential of MSCs to different lineages has varied
considerably among different sources. BM-MSCs have shown differentiation potential
towards osteoblasts, chondrocytes, adipocytes, tenocytes and vascular smooth muscle
cells. Umbilical cord blood-derived MSCs have shown the ability to give rise to
osteoblasts,

chondrocytes,

adipocyte,

skeletal

muscle

cells,

endothelial

cells,

cardiomyocytes-like cells and neurons. However, periosteum-dervied MSCS have the
capacity to generate only osteoblasts and chondrocytes (Via et al., 2012).
7

1.3.4. Expression of pluripotency markers
Mesenchymal stem cells possess similar properties to embryonic stem cells in
terms of their self renewal and differentiation capacities, although to a less extent in
MSCs. Therefore, the expression of pluripotency markers has been widely investigated in
MSCs to determine if they regulate their stemness properties. Many studies have
demonstrated the expression of pluripotency factors in MSCs and their role in regulating
MSCs properties. One study reported the positive expression of OCT4, SOX2 and
NANOG in human MSCs and that it controls the same regulatory circuitry of ESCs.
Also, it reported that Oct4 regulated MSC cycle progression (Greco et al., 2007). In
2014, a study reported that adipose tissue-derived MSCs express Oct4, Sox2 and Nanog
(Taha et al., 2014). However, the expression and role of pluripotency markers have been
controversial topics. Other studies reported that human MSCs express NANOG but not
OCT4 or SOX2 (Lengner et al., 2007; Pierantozzi et al., 2010).

1.4.Mesenchymal stem cells in therapy
The multipotency potential of MSCs together with its presence in a variety of
different tissues strongly poses a critical role of MSCs in injury healing. MSCs become
recruited for growth, wound healing, and replacing cells. Therefore, they have been
shown to have great promise in the treatment of tissue injury and degenerative diseases.
Transplantation of autologous bone marrow mesenchymal stem cells (BM-MSCs) in the
digestive system, improved liver function in liver cirrhosis and liver failure patients
caused by hepatitis B (Kharaziha et al., 2009; Peng et al., 2011). Also, BM-MSCs have
been shown to have strong therapeutic potential in the musculoskeletal system. In fact,
several studies have reported the effectiveness of BM-MSCs in the regeneration of
diabetic critical limb ischemia, periodontal tissue defects and burn-induced skin defects
(Rasulov et al., 2005; Yamada et al., 2006; Lu et al., 2011). Preclinical studies have
shown the effectiveness of human MSCs in treating myocardial infarction and cornea
damage by reducing inflammation and promoting tissue reconstruction (Lee et al., 2009;
Roddy et al., 2011). The ability of MSCs to regulate immune responses is the reason
behind their use in immune disorders. For example, MSCs have been successfully
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utilized to reverse graft-versus-host disease (GvHD) in patients receiving bone marrow
transplantation (Müller et al., 2008; Prasad et al., 2011).

1.5.Isolation techniques of MSCs
To date there are a variety of protocols published on the different isolation
methods for MSCs. However, they report non-comparable data. The first and simplest
method used involves adherence to plastic property of MSCs. A modification of this
technique included the density centrifugation of BM like Ficoll and Percoll that involve
the separation of a mononucleated fraction of BM which contains MSCs. Afterwards,
plastic adherence is utilized resulting in a population of MSCs (Lennon and Caplan,
2006). For sources other than the bone marrow like cartilage and fat, collagenase
digestion process is often used as an enzymatic treatment to isolate the cells from tissues.
Collagenases are enzymes capable of cleaving the peptide bonds in the triple helical
collagen molecule. Accordingly, cells can be easily cleaved from tissues and collected
(Pountos et al., 2007). Collagenase treatment was found to yield 100 times more MSCs
compared to BM aspirates (Sakaguchi et al., 2004). However, it was reported that MSCs
isolated using enzymatic procedures possess a higher metabolic activity and lower
alkaline phosphatase (ALP) activity which might cause changes in the metabolic profile
of MSCs (Thomas et al., 2004). The major problem in the previously mentioned
techniques is the presence of contaminating cells which result in heterogeneity of the
population.
Two similar techniques called the magnetic bead sorting technique (MACS) and
fluorescence-activated cell sorting (FACS) have been developed to generate pure
populations of MSCs. Magnetic bead sorting is based on labeling antigens positive for
MSCs with antibody-coated magnetic beads. Therefore, when a magnetic field is applied,
the positively labeled cells can be separated (Inokuchi et al., 2005). Fluorescenceactivated cell sorting (FACS) is based on labeling the desired population of cells with one
or several monoclonal antibodies tagged with a fluorescent dye, cells positive and
negative for the labeled antibodies can be separated based on the intensity of fluorescence
they emit (Baumgarth and Roederer, 2000; Tung et al., 2004). However, the
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limitations of FACS include the high cost and the complicated process of data analysis
(Jahan-Tigh et al., 2012; Shapiro et al., 2013).
Adhesion of MSCs to Extacellular Matrix Proteins (ECM) has been extensively
studied especially in clinical-based research. ECM is an important part of the cellular
microenvironment and it plays a major role in deciphering the cell behavior and function
by governing cell adhesion, migration, differentiation, proliferation and apoptosis
(Hidalgo-Bastida and Cartmell, 2010). Collagen type I, elastin, laminin, fibronectin and
vitronectin are the major proteins present in the ECM. Collagen type I is the major
protein present in the ECM of bone. Laminin is present in basal laminae and they assist in
cell adhesion. Fibronectin and vitronectin are present in ECM as well as in serum and
they promote cell adhesion and spreading (Underwood and Bennett, 1989; Mizuno and
Kuboki, 2001; Mochizuki et al., 2003). Mesenchymal Stem Cells were found to bind to
ECM proteins collagens, laminins, fibronectin and vitronectin in an integrin-mediated
fashion (Finne-Wistrand et al., 2012; Roncoroni et al., 2013). Enrichment for cells
using ECM proteins has been used previously. Adherence to collagen IV has been used to
enrich for tumour initiating cells in oral cancer. In 2012, collagen type IV was also used
to enrich and characterize human dermal stem/progenitor cells (Shim et al., 2012; Liang
et al., 2014). However, to date, the use of extracellular matrix proteins for the enrichment
of MSCs hasn’t been widely investigated.

1.6. The testis as a new source of MSCs
There are very few reports on the isolation of MSCs from the testis; two on
human derived MSCs (Gonzalez et al., 2009; Chikhovskaya et al., 2013) and one
isolated from the marmoset monkey (Eildermann et al., 2012). All studies reported the
multipotency differentiation potential of the isolated cells and expression of MSC surface
markers. Also, they report that testis-derived MSCs are not of germ cell origin.
Chikhovskaya and colleagues reported culturing human testis-derived stem cells which
grew in the form of colonies but Gonzalez et al. and Eildermann et al. reported the
appearance of fibroblast-like cells. Also, Chikhovskaya reported that the isolated cells
were cultured for 4 to 6 passages in 50 days but Gonzalez reported that the isolated MSCs
could be cultured for 17 passages. However, Eilderman did not elaborate on the
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proliferation pattern of the isolated cells. In conclusion, the available studies on the
isolation of MSCs from the testis are few and report some inconsistent data which
generates the need to conduct more studies on testis-derived MSCs from different sources
to understand more how they behave and proliferate in vitro (Gonzalez et al., 2009;
Eildermann et al., 2012; Chikhovskaya et al., 2013).

1.7. Objectives and Experimental Plan


The main objective of the proposed study is to utilize the mouse model, for the
first time, to isolate and culture testis-derived Mesenchymal Stem Cells (tMSCs).
To achieve this purpose, an enrichment technique was utilized based on adhesion
of MSCs to laminin followed by subsequent propagation on gelatin-coated dishes.



The second aim of our study is to characterize the isolated cells for cell surface
markers characteristic of MSCs (CD44, CD73 and CD29) and hematopoietic cells
(CD45), compare their expression levels with the starting population (Testicular
cell suspension) and investigate the effect of serial passaging on these markers.



The third aim was to investigate the origin of the isolated cell population by
investigating the expression of the germ cell marker Vasa.



The last objective of our study was to assess the expression of the pluripotency
markers Nanog and Oct4 in tMSCs.

To achieve our objectives, testes of CD-1 male juvenile mice were harvested and
exposed to a series of enzymatic digestion and plating steps to enrich for tMSCs. The
enriched population was cultured in vitro and aliquots from every passage were processed
for RNA analysis to assess the expression levels of genes of interest. Cell suspensions
from early passages were analyzed by flow cytometry.

11

2. Materials and Methods
2.1.Animals
Male CD-1 Swiss albino mice (4-5 weeks old) were obtained from the
experimental animal research unit at Theodor Bilharz Research Institute (TBRI, Giza,
Egypt). At the institute, animals were maintained on a standard commercial pellet diet
(El-Kahira Company for Oils and Soap, Cairo, Egypt). The animals were given carrot,
lettuce and milk as a source of vitamins. Animal experiments were carried out according
to internationally valid guidelines.
2.2.Primary Cell Cultures
2.2.1.

Preparation of testicular single cell suspensions
Three independent enrichment experiments were performed utilizing a total of 12

male mice. Mice were euthanized and dissected. Then, testes were harvested and washed
three times in sterile filtered Phosphate Buffered Saline (PBS) (Lonza, Switzerland). For
each experiment, the testes of 4 mice were pooled together. In sterile conditions, testes
were placed in a 100 mm cell culture dish (Corning, USA) and cut into small pieces using
a sharp blade.
The cut fragments were exposed to a two-step enzymatic digestion procedure
(Guan et al., 2009). Briefly, fragments were incubated with sterile filtered 1 mg/ml
collagenase type IV (Worthington Biochemical Corp, USA) in Dulbecco’s Modified
Eagle Medium (DMEM, GIBCO, USA) (4-5 ml/ mouse) for 20 minutes at 37°C in a CO2
incubator (Shellab, USA) or until the tubules dispersed. The resulting fragments were
centrifuged using (Eppendorf, Germany) at 200xg for 5 min at 15–25°C, then washed
with PBS, centrifuged again and incubated with 3ml/mouse of trypsin (GIBCO, USA).
After incubation for 5 minutes at 37°C, the tubule fragments were dispersed by pipetting
and trypsin was inactivated by adding serum-containing media. The resulting mixture
was filtered using a sterile 70-μm pore size Nylon mesh (BD Bioscience, USA). Aliquots
of the testicular cell suspension were taken for molecular testing.
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2.2.2. Enrichment for tMSCs using laminin-coated dishes
To prepare laminin coated dishes, 60 mm cell culture dishes were incubated with
2 ml of laminin solution (20μg/ml in PBS, Sigma-Aldrich Co., USA) for at least 3 hours
in 37°C incubator. After removal of laminin, dishes were washed with PBS. Testicular
cell suspensions were plated on laminin-coated dishes at the density of 4-5x106 cells /dish
to enrich for tMSCs. After incubation for 15-20 minutes at 37°C in a CO2 incubator, the
adherent cells were washed gently with PBS, trypsinized and seeded on 6-well plates
coated with 0.1% gelatin solution (Sigma, USA) at the seeding density 70,000 cell/ cm2
in tMSC culture media. A pilot study was performed by culturing non-laminin bound
fraction of testicular cell suspension under the conditions mentioned above. The steps for
tMSCs enrichment have been summarized in a schematic diagram (Figure 1).
tMSC primary cells were cultured in complete media composed of Minimum
Essential Medium (α-MEM, GIBCO, USA) supplemented with 1% Fetal Bovine Serum
(FBS, GIBCO, USA), 5% penicillin/streptomycin (GIBCO, USA), 1X Non-Essential
Amino Acids (NEAA, GIBCO, USA), 1X β-Mercapto Ethanol (β-ME, 10 mM, Serva,
Germany), 0.2% Bovine Serum Albumin (BSA, GIBCO, USA), 1X Bottenstein’s N2
supplement (Life Technologies, USA), 20 ng/ml recombinant rat Glial Cell Line-derived
Neurotrophic Factor (GDNF, R&D Sciences, USA), 10 ng/ml basic Fibroblast Growth
Factor (bFGF, Life Technologies, USA) and 1000 U/ ml recombinant human Leukemia
Inhibitory Factor (LIF, Life Technologies, USA). Upon reaching 80-90% confluence
corresponding to ≈50,000 cells/cm2, Cells were trypsinized and split at the ratio 1:3 or 1:4
on gelatin-coated dishes. Cultured cells were regularly examined for morphological
characterization and tracking morphological changes while passaging using inverted
microscope (Olympus 1X70, USA).

2.3.Viable Cell Count
For tMSCs, the viable cell count was determined at every passage by trypan blue
exclusion staining. For each count, 20 µl of cell suspension was stained with 20 µl 0.4%
trypan blue (Sigma, USA) and viable cells were counted using a hemocytometer (Hausser
Scientific, USA).
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2.4.Population Doubling Time (PDT)
To analyze the growth kinetics of tMSCS, the PDT was calculated at every
passage according to the following equation: TD = tplog2/(logNt-logNo). Where Nt is the
number of cells harvested, whereas No is the number of cells seeded, and t is the time of
the culture (in hours). The trypan blue exclusion test was used to count the cells with the
hemocytometer.

2.5.Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
Total RNA was extracted from cell pellets of tMSCs at different passages (P0, P1,
P2, P3, P4, P5 and P6) using Trizol® (Invitrogen, USA) as per manufacturer's protocol.
RNA was extracted from pellets of the starting population (Testicular cell suspension)
prior to enrichment for comparison. Then, RNA was dissolved in diethylpyrocarbonate
(DEPC) treated water and was quantified at A260mm using Shimadzu spectrophotometer
UV-1800. cDNA was synthesized from 1 μg of RNA using RevertAID™ First Strand
cDNA synthesis kit (Fermentas, USA) according to the manufacturer’s instructions.
An aliquot of 1 µl of the cDNA was then added to the reaction mixture using
mouse specific forward and reverse primers. The sequences of the primers used to
analyze the following genes; CD44, CD73, CD29, CD45, Nanog, Oct4, Vasa and the
loading control β-actin are listed in Table 1. The mixture consisted of 1 µM of each
primer, 2 μl of 10X DreamTaq Buffer, 1 μl of 10 mM dNTP Mix and 1U of DreamTaq
DNA Polymerase (Fermentas Inc, USA). The reaction was completed with nuclease free
water to form a total mixture of 20 μl. A negative control was prepared for each run
without the template cDNA to detect any contamination or non-specific amplification in
the reaction. PCR reaction mixture was then thermal cycled on a Veriti® Thermal Cycler
(Applied Biosystems, USA) using primer-specific cycle programs.
The amplified PCR products were electrophoresed on 1.5% agarose gel. For
amplified products of Nanog, 12% acrylamide gel was used to resolve a difference of
three base pairs between two amplicons. Acrylamide gel was prepared as follows: 3.2 ml
Acrylamide/bisacrylamide 29.2 :0.8 was added to 2 ml Distilled water, 2.6 ml 1.5 M
Tris pH 8.8, 135 µl 10% Ammonium Persulfate (APS, ThermoScientific, USA) and 15 µl
Tetramethylethylenediamine (TEMED Plus One, GE Healthcare, USA) with total volume
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of 8 ml. The gels were visualized with ethidium bromide (Sigma, USA) and
photographed under UV light using GelDoc (Bio-rad, USA). The resulting images were
assessed by densitometric analysis of the bands using ImageJ software (NIH, USA). The
intensity of each band was normalized against its corresponding β-actin band to compare
values between samples. For Nanog variants, the densities of the two bands (580 bp and
583 bp) were compared relative to each other as percentage means.
Spidey sequence alignment and primer blast tools were used to determine the structure of
the different alternatively spliced variants in Nanog and the amplified sequences.
Table 1. Sequences of primers used in the study, amplicon size and cycling
conditions.

Gene

Sequence

Annealing

size

Temperature

469 bp

67°C

32

241 bp

47°C

34

271 bp

60°C

33

655 bp

62°C

32

66°C

35

429 bp

63°C

33

420 bp

57°C

25

460 bp

60°C

27

Mouse

F-5'TCCAGGGGGAGTTCCCGCAC3'

CD44

R-5'GGAGGGTCCCAGCTCCCAGCTCCCAGG3'

Mouse

F-5'TTGGCAAATACCTGGGCTAC3'

CD73

R-5'AGGTTTCCCATGTTGCATTC3'

Mouse

F-5'GTGACCCATTGCAAGGAGAAGGA3'

CD29

R-5'GTCATGAATTATCATTAAAAGTTTCCA3'

Mouse

F-5'TGCTCCTCAAACTTCGACGGA3'

CD45

R- 5'CTGCCAAAAGTCACCGATCGT3'

Mouse

F-5'GGCTGCCTCTCCTCGCCCTT3'

583 bp

Nanog

R-5'CCAAGGCTGGCCGTTCCAGG3'

580 bp

Mouse

F- 5'TGGTGCAGGCCCGGAAGA3'

Oct4

R-5’AGCATCCCCAGGGAGGGC3’

Mouse

F-5'GGTCCAAAAGTGACATACC

Vasa

R-5'TTGGTTGATCAGTTCTCGAGT3'

Mouse

F-5'ACGCAGGATTTCCCTCTCAGC3'

B-actin

R-5'GGCCCAGAGCAAGAGAGGTAT3'
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2.6.Flow Cytometry
Testiscular cell suspensions and cultured tMSCs were stained with antibodies for
immunophenotypying using fluorescence-activated cell sorting (FACS) analysis. Briefly,
tMSCs were harvested using trypsin for 5 min at 37°C, after deactivation, approximately
5 × 105 cells were recovered by centrifugation at 450 xg for 5 mins. Afterwards, cells
were resuspended in ice-cold PBS as a washing step, centrifuged again and incubated
with PE-conjugated CD44 antibody (Beckman Coulter, Mexico) and FITC-conjugated
CD45 antibody (Beckman Coulter, Mexico). Cells were stained for 30 minutes at 4°C in
the dark with the antibodies. After washing using PBS, samples were analyzed on a
COULTER Epics XL flow cytometer (Beckman Coulter, USA) and at least 10,000 events
were acquired for each population. Data acquisition and analysis were performed using
XL SYSTEM II™ software (Beckman Coulter, USA). All experiments included negative
controls that represented unstained cells to adjust threshold positivity.

2.7.Statistical Analysis
Data are presented as mean±SD of two or more independent experiments.
Comparisons were carried out using one-way analysis of variance (ANOVA) followed by
Tukey– Kramer’s test for post hoc analysis. Statistical significance was acceptable to a
level of P<0.05. To compare the different expression patterns of Nanog transcript
variants, two-way ANOVA was used followed by Bonferroni’s test for post hoc analysis.
All statistical analyses were performed and plotted using GraphPad Prism software,
version 5.00 (GraphPad Software, USA).
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Figure 1. Representation of the cell isolation procedures, culture conditions and
plating densities for the isolation of tMSCs.
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3. Results
3.1.Enrichment for testis-derived Mesenchymal Stromal Cells (tMSCs)
A total of 12 male Juvenile CD-1 mice (4-5 weeks) with average weight
7.27±1.63 (gm±SD) were sacrificed in three independent experiments. Following manual
teasing and enzymatic digestion with collagenase type IV and trypsin, the cellular
suspension consisted of free and single cells. The viable cell count of the cell suspension
yielded an average count of 2.34±0.49 (x106±SD)/ paired testes, where the cell viability
was found more than 90% throughout the experiments. Incubating the testicular cell
suspension on laminin-coated dishes at the plating density ≈2.25x105/cm2, yielded an
average of 3.71±0.81 (x105 ±SD)/ paired testis adherent cells constituting ≈16% of the
initial cell suspension. Details of mice weights and cell yields are summarized in Table 2.
Laminin-bound cell fraction was seeded on gelatin coated dishes in tMSC media.
Cells started to adhere around 12 hours post plating and spindle-shaped fibroblast-like
cells were noticed to appear 24-36 hours post plating (Figure 2A, 2B). Media was
changed after 48 hours to remove non-adherent cells and after around 4 days from the
start of enrichment experiments, tMSCs reached 80%-90% confluence which comprised
around 50,000 cells/cm2. At this stage, tMSCs were termed “Passage 0” and were ready
to be propagated.
3.2.Culturing tMSCs
At passage 0, cells were morphologically found to be highly heterogeneous
having both round and spindle shaped cells (Figure 2 A). Heterogeneity of the population
seemed to decrease with subsequent passaging becoming nearly homogeneous at passage
2. tMSCs were cultured in vitro for 4-9 passages, the cells were plastic adherent and
during early passages from passage 1 to passage 5 (Figure 2, C-F), they maintained the
bipolar spindle-shaped morphology. Upon confluency, the monolayer exhibited a
constant orientation and whirling tendency. Interestingly, colonies resembling those of
embryonic stem cells (ESCs) appeared in confluent cultures of passages 1 and 2 (Figure
3A and 3B). However, they disappeared with later passages. Although, Population
Doubling Time (PDT) gradually increased with subsequent passaging (Figure 4), tMSCs
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of early passages (1-5) exhibited a relatively high proliferation pattern with average PDT
(47.7±10 hr.). The average time it took for tMSCs to reach 80-90% confluence was
around 3-5 days depending on the seeding density.
Starting with passage 6 (Figure 2G), a change in morphology started to appear
that was more prominent in later passages (P7-P9). Gradually, cells showed an irregular
morphology, they became flattened, enlarged with circumscribed nucleus and increased
debris in the medium (Figure 2H). Also, PDT was increasing with later passages until it
became significantly different at passage 7 compared to passage 4 (Figure 4). On the
other hand, although fibroblast-like cells appeared in the non laminin-bound fraction,
they couldn’t be propagated beyond passage 1.

Table 2. Mice weights and cell yields generated throughout experiments

1

2

3

Weight
(gms)
6.8
5.8
5
5.7
6.9
6.4
6.9
8.2
10.1
9.94
6.86
8.7

Average
weight
(gms)

Cell yield/
paired
testes

5.82 ±0.74

1.9 x106

7.1 ±0.77

2.87 x106

8.9 ±1.49

2.25 x106
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Seeding
density
in
laminin

Cell yield after
laminin
enrichment/
paired testes
2.85 x105

2.25x105/cm2

Experiment

4.45 x105

3.85 x105
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Figure 2. Morphological examination of cultured testis-derived Mesenchymal Stromal Cells in different
passages using inverted microscopy. (A) Adherent cells two days post isolation showing fibroblast-like cells
(arrows) and round-shaped cells (arrow heads) (x100). (B) High power image showing bipolar spindle-shaped
morphology (arrows) (x 400). (C), (D), (E), (F) and (G) tMSCs after expansion at passages 1, 2, 3, 5 and 6,
respectively. (H) Passage 8 tMSCs showing change in morphology, cells became flattened and irregular with
circumscribed nucleus (x 100). Insets in (E) and (H) depict the morphology difference.

Population Doubling Time (hr.)

Figure 3. Morphological examination of a tMSC colony. (A) Low (x100) and (B) high
power (x400) images of a tMSC colony (arrows) at passage 1, respectively.

*

100
80
60
40

P1
P2
P3
P4
P5
P6
P7

20
0

Passage no.

Figure 4. Figure 4. Population Doubling Time (PDT) of tMSCs. A significant increase
in PDT started to appear at passage 7. Data are presented as mean±SD of two
independent experiments. P: Passage. * significantly different at p < 0.05.
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3.3.Expression patterns of MSC surface markers at the RNA level
RT-PCR data revealed the high expression of CD44 steady state mRNA levels in
tMSCs from passage 0 to passage 6 (Figure 5). Interestingly, the expression levels were
significantly higher than the testis with ≈9.6 folds at passage 0. The expression pattern
remained elevated and at comparable levels throughout different passages.

Figure 5. Expression of CD44 surface marker in tMSCs during continuous passages
by RT- PCR. (A) Representative RT-PCR gel image for CD44 (469 bp) and the loading
control β-actin (460 bp). (B) Bar chart representing normalized expression values relative
to the loading control. Data are presented as mean±SD of at least two independent
experiments, P: Passage. *: significantly different at p < 0.05, **: significantly different
at p<0.01.
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CD73 and CD29 transcript levels revealed the positive expression of both markers
(Figures 6 and 7). Both markers displayed no significant change in their expression from
the testis. A gradual decrease in expression pattern of CD73 was noticed until it became
significantly low at passage 6 compared to passage 4 (Figure 6). CD29 maintained a
relatively elevated expression pattern throughout different passages until it sharply
decreased at passage 6 and became significantly different from the previous passages
(Figure 7).

Figure 6. Expression of CD73 surface marker in tMSCs during continuous passages
by RT- PCR. (A) Representative RT-PCR gel image for CD73 (241 bp) and the loading
control β-actin (460 bp). (B) Bar chart representing normalized expression values relative
to the loading control. Data are presented as mean±SD of at least two independent
experiments, P:Passage. *: significantly different at p < 0.05, **: significantly different at
p <0.01.
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Figure 7. Expression of CD29 surface marker in tMSCs during continuous passages
by RT- PCR. (A) Representative RT-PCR gel image for CD29 (271 bp) and the loading
control β-actin (460 bp). (B) Bar chart representing normalized expression values relative
to the loading control. Data are presented as mean±SD of at least two independent
experiments, P: Passage. *: significantly different at p < 0.05, **: significantly different
at p < 0.01.

24

3.4.Expression pattern of hematopoietic cell surface marker (CD45) at the RNA
level
The steady state RNA levels of CD45 cell surface marker were negligible among
all passages of tMSCs (Figure 8). The expression levels of the testicular cell suspension
were ≈11.25 folds higher than passage 0 tMSCS. In subsequent passages, CD45 became
absent or of extremely low levels.

Figure 8. Expression of hematopoietic cell marker in tMSCs during continuous
passages by RT- PCR. (A) Representative RT-PCR gel image for CD45 (655 bp) and
the loading control β-actin (460 bp). (B) Bar chart representing normalized expression
values relative to the loading control. Data are presented as mean±SD of at least two
independent experiments, P: Passage. ***: significantly different at p < 0.001.

Taken together, the data obtained for the mRNA steady state levels of CD44,
CD73, CD29 and CD45 indicated that the status of propagated tMSCs changed after
passage 5. It seems that tMSCs at P6 assume a different path than mesenchymal stem
cells. Therefore, to distinguish between the two populations, we classified tMSCs into an
early stage (from P0 to P5) and a late one (P6). Then, we compared both stages to each
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other and to the testis. CD44 had significant higher expression in tMSCs when compared
to the levels of testis. In tMSCs, the pattern of expression of CD44, unlike CD73 and
CD29, remained elevated throughout the tested passages. CD73 and CD29 showed
comparable expression levels in the testis and early tMSCs, while CD45 had a significant

CD44, CD73, CD29 and
CD45/ -actin Relative densitiy A.U.

higher expression in testis over tMSCs.

2.0

CD44
CD73
CD29
CD45

1.5
1.0
0.5
0.0
Testis

Early tMSCs Late tMSCs

Figure 9. Graphical representation of the steady state RNA levels of CD44, CD73,
CD29 and CD45 in testis, early tMSCs and late tMSCs. Early tMSCs represent the
average expression levels of passages 0 to 5, while late tMSCs represent passage 6. Data
are presented as mean±SD of at least two independent experiments where 1 μg of RNA
was consistently used. Expression values are normalized relative to the loading control
(β-actin).
Table 3. Significant differences of the mean expression values of surface markers
(CD44, CD73, CD29 and CD45) between testis, early tMSCs and late tMSCs.
Marker

Testis and Early
Testis and Late
Early and late
tMSCs
tMSCs
tMSCs
***
***
Ns
CD44
Ns
***
**
CD73
Ns
***
***
CD29
***
***
Ns
CD45
**: Significantly different at p<0.01, ***: significantly different at p<0.001
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3.5.Immunophenotyping
Immunophenotyping using flow cytometric analysis was performed for the
mesenchymal stem cell marker CD44 and the hematopoietic cell marker CD45 on
testicular cell suspensions and tMSCs at passages 1 and 2. Percentages were calculated
using the Median Fluorescent Intensity (MFI). Data showed that a high percentage of
tMSCs expressed CD44 cell surface marker (>70 %) while low percentage of cells
expressed CD45 (<7%) (Figure 10). On the other hand, a low percentage of cells in the
testicular cell suspensions expressed both markers; CD44 <18% and CD45 <14%,
detailed percentage means are presented in Table 4. When comparing the percentage of
cells expressing both markers in tMSCs and testis, CD44 is found to be higher in tMSCs
by ≈ 4.12 folds while CD45 is found to be lower in tMSCs by ≈0.5 folds.
Table 4. Percentage means of the immunophenotypic characterization of testis and
tMSCs by flow cytometry. Data are presented as percentage means of passages 1 and 2
±SD.

Testis
tMSCs

CD44
17.5±9.1
72.1±7.9

CD45
13.2±4.2
6.9±1.5
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Figure 10. Immunophenotyping of tMSCs. Flow cytometric analysis of mesenchymal stem cell marker CD44
and hematopoietic cell marker CD45 in testicular cells (A) and tMSCs (B). Unstained cells were used as a
negative control (shaded curves). Y-axis: No. of events, x-axis: Log scale of fluorescent intensity. Figures are
representative of two different preparations from two independent experiments.

3.6.Investigation of the cellular origin of tMSCs
To investigate whether tMSCs originated from a germ cell origin or not, we
assessed the steady state RNA levels of the germ cell marker Vasa at passages 1 and 3.
RT-PCR data showed the negative expression of Vasa in tMSCs (Figure 11A). Vasa
displayed significantly low/no expression levels in tMSCs at P1 when compared to the
high levels of expression in the testis and it was absent in the subsequent passages
(Figure 11 B).

Figure 11. Analysis of cellular origin of tMSCs by RT- PCR. (A) Representative RTPCR gel image for the germ cell marker Vasa (420 bp) and the loading control β-actin
(460 bp). (B) Bar charts representing normalized expression values relative to the loading
control. Data are presented as mean±SD of three independent experiments, P: Passage.
***: significantly different at p<0.001.
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3.7.Investigation of the transcript levels of pluripotency markers
RT-PCR results revealed the lack of expression of Oct4 in tMSCs, while testis
gave a weak expression (Figure 12). As for Nanog, RT-PCR was performed using
primers which have four potential targets; they can detect variant 2 at a band of 580 bp
and variants 1, 3 and 4 at a band of 583 bp (Figure 13). Therefore, the 580 bp amplicon
reflects the expression pattern of variant 2, but the 583 bp amplicon does not distinguish
between the expressions of the remaining variants because it amplifies a conserved
sequence in them. tMSCs expressed Nanog throughout different passages (Figure 14A).
In the testis, the transcript levels of variant 2 at 580 bp were found to be significantly
higher than those of the variant(s) at 583 bp with ≈ 9.59 folds. Interestingly, in tMSCs,
the levels of variant(s) at 583 bp started to increase, meanwhile those of variant 2
decreased reaching a significant fold change of ≈ 11.98 between the two bands in P3
(Figure 14B). In general, it was found that variant 2 decreased significantly from testis to
tMSCs, while the variant(s) at 583 bp displayed a significant increase from testis to
tMSCs (Figure 14C).

Figure 12. Expression of Oct4 in tMSCs by RT- PCR. (A) Representative RT-PCR gel
image for Oct4 (429 bp) and the loading control β-actin (460 bp). (B) Bar chart
representing normalized expression values relative to the loading control. Data are
presented as mean±SD of at three independent experiments, P: Passage. *: significantly
different at p < 0.05.
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Figure 13. Schematic diagram of alternatively spliced mouse Nanog variants.
Primers utilized throughout experiments (colored regions) have four possible Nanog
targets; variants 1, 2, 3 and 4. The amplicon generated from variant 2 is 580 bp. Variants
1, 3 and 4 generate amplicons of equal size; 583 bp. The sequence amplified from
variants 1, 3 and 4 is a conserved one.
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Figure 14. Expression of Nanog transcript variants in tMSCs by RT- PCR. (A)
Representative gel image of the different expression patterns of variant 2 at 580 bp and
variant(s) at 583 bp in the testis, P1 and P3. (B) Stacked bar chart representing variation
in expression of variant 2 at 580 bp and variant(s) at 583 bp, presented as percentage
means. (C) Bar chart showing the pattern of expression of each band in the testis, P1 and
P3, expression values are normalized relative to the loading control (β-actin). Data are
presented as mean±SD of three independent experiments. #: Significant difference
between variant 2 at 580 bp and variant(s) at 583 bp at p<0.01, Φ: Significant difference
between variant 2 at 580 bp and variant(s) at 583 bp at p<0.001, **: Statistically
significant at p<0.01. ***: Statistically significant at p<0.001.
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4. Discussion
Since their initial isolation from the bone marrow in 1967, Mesenchymal stem
cells have been the subject of interest of many researchers. Over the past decades, the
research community has been flooded with studies on MSCs isolated from different
sources and different species. The main focus of these studies was to characterize MSCs,
expand them in culture, understand more about how they behave in vivo and most
importantly, investigate their trilineage differentiation potential. MSCs are considered the
most commonly used stem cells in current clinical applications, because of their low risk
of developing teratomas, low immunogenicity and they have numerous sources. (Wei et
al., 2013).
One of the major hurdles in MSC research is the low yield of MSCs isolated from
different sources that might be related to the techniques used for their isolation.
Conventionally, most researchers use culturing on plastic plates as the primary method
for isolating and culturing anchorage dependent cells (Zangi et al., 2006). However,
beside the fact that plastic adherence results in low cell count especially for BM-MSCs,
the cultured cells reflect heterogeneous populations that often contain contaminating
cells. To date, several techniques have been developed to obtain pure cultures of MSCs
by the reduction or elimination of cells other than MSCs or by enriching for MSCs
(Nadri et al., 2007). Still, the search is ongoing for a simple and efficient method for
isolating an MSC population with high degree of homogeneity.
Few reports have been published recently on the isolation of mesenchymal stem
cells from the testis. Although, these studies report similar multipotency potential of the
different isolated populations, their surface marker profiles are not entirely consistent and
they had little emphasis on the expansion patterns of the cultured cells in vitro (Gonzalez
et al., 2009; Eildermann et al., 2012; Chikhovskaya et al., 2013). The testis is a highly
heterogenous population containing a myriad of different cell types like Sertoli, Leydig,
peritubular myoid, endothelial and many other cell types (Desjardins and Ewing, 1993).
Needless to say, utilizing an enrichment protocol for MSCs will aid in generating a more
homogenous population of cells from early passages.
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The aim of our study was to isolate MSCs from the mouse testis using a laminin
based-enrichment method. Then, culture the isolated cells in vivo and investigate their
surface marker expression profiles.
4.1.Laminin to enrich for MSCs
In our study, we describe a simple method to enrich for MSCs from testicular cell
suspensions based on positive selection on the ECM ligand laminin. Three out of three
(100%) cultures of adherent cells generated from the enrichment technique, led to the
establishment of tMSC cultures that could be successfully propagated for up to 9
passages. Failure to produce cultures from the non-laminin-bound fraction gave us further
confirmation that the enrichment technique was successful. The laminin-mediated
enrichment method is based on the cell binding capacity of laminin towards
mesenchymal cell types that results in a rapid and simple selection of MSCs from mixed
testicular preparations. Adhesion to laminin is mediated through interaction with
integrins found on the surface of MSCs. In fact, studies by Gronthos et al. showed that
monoclonal antibody against β1 integrin affected the binding of human bone marrow
stromal precursor cells to laminin (Gronthos et al., 2001). Also, MSC were found to
bind with higher efficiency to laminin-111 (the same type of laminin utilized in our
studies) when compared to fibroblasts (Roncoroni et al., 2013).
The homogenous population observed with early passages (passage 2) is
suggestive that the enrichment technique was efficient. A high yield of cells was
generated from the laminin selection step, where around 16% of the cells present in
testicular cell suspensions adhered to laminin. It is expected that this percentage doesn’t
reflect an entirely pure population of tMSCs based on the presence of a contaminating
fraction of non-adherent cells in the subsequent culturing steps. The yield of MSCs
generated, varied significantly among different studies depending on the method of
isolation. However, it is considered a high percentage when compared to the low yield of
cells generated by plastic adherence. In fact, several studies showed that MSCs represent
only 0.01% to 0.001% of nucleated cells generated from bone marrow aspirates isolated
by plastic adherence (Majors et al., 1997; Muschler et al., 2001; Marcantonio et al.,
2009). In 2010, a modified method was generated to isolate murine bone marrow MSCs,
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the method involved enzymatic digestion procedures followed by immunodepletion and it
resulted in an increased yield of cells up to 6.6% (Xu et al., 2010). It is worth mentioning
that a study was published in 2006 in which Fibrin Microbeads (FMB) were designed to
isolate and expand a high yield (4.9%) of rat bone marrow–derived Mesenchymal Stem
cells. This study was based on the high interaction properties of fibrin with MSCs which
is a similar principle to the laminin-based enrichment (Zangi et al., 2006).
Magnetic activated cell sorting (MACS) or fluorescence activated cell sorting
(FACS) are techniques commonly used for the isolation of MSCs using specific MSCsurface antigens to select for the cells (Bosio et al., 2009). However, Laminin-based
enrichment is not considered a highly specific method that selects only for the desired
cell population. It is expected that the laminin-bound population is not a pure one, but it
contains other cell types albeit at lower ratios to the original testicular cell population. In
fact, laminin was found to bind to spermatogonial stem cells (SSCs) which represent a
rare population in the testis (0.01%). However, SSCs are eliminated by the subsequent
culture on gelatin-coated dishes since SSCs do not to bind to gelatin (Wu et al., 2009).
Therefore, laminin enrichment could be regarded as a simple, rapid and cost-effective
method for generating cell populations enriched with a high proportion of MSCs.
4.2.Successful propagation of tMSCs
tMSCs were successfully cultured in vitro for several passages. The cells
displayed a morphological profile identical of MSCs reported in the literature (Ahrari et
al., 2013; Dehghani, 2015). Also, tMSCs displayed clusters or colonies of cells upon
confluence which is a feature previously reported in testicular multipotent stromal cells
isolated from the marmoset monkey (Eildermann et al., 2012). Interestingly, tMSCs
showed an initial shorter lag or adaptation phase compared to those reported in the
literature. Barberini et al. compared the proliferation patterns of MSCs isolated from
different tissue sources and found that it took around 11, 7 and 15 days for BM-MSCs,
AT-MSCs and umbilical cord-derived MSCs (UC-MSCs) to reach confluence,
respectively (Barberini et al., 2014). As for MSCs isolated from adult human testes,
Gonzalez et al. reported that the cells required 7-10 days to reach confluence (Gonzalez
et al., 2009). However, in our study, it took almost 4 days for tMSCs to reach confluence.
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During early passages (passages 1 to 5), tMSCs displayed a high proliferation
pattern with an average PDT of 47.7 hours. Adult human testis derived MSCs displayed
higher proliferation patterns of average PDT of 33.8 hrs. (Gonzalez et al., 2009).
However, it is well established that the proliferation patterns of MSCs vary among
different protocols due to variations in culture media, source of the cells and growing
conditions. In fact, tMSCs display high proliferation patterns when compared to other
reports from different sources; the doubling time of human AT-MSCs was found about 4
days (Mitchell et al., 2006). Also, in a study conducted to compare between the growth
kinetics of MSCs isolated from different sources, it was found that BM-MSCs, AT-MSCs
and periosteum derived cells at passage 2 displayed high PDT of 3.99 days, 4.65 days and
3.55 days, respectively (Tawonsawatruk et al., 2012).
The fast establishment of tMSC cultures and their marked high proliferation
patterns in early passages might be attributed to several factors. Culturing the cells on
gelatin-coated dishes could have had a potential role, gelatin-coated matrix was
previously reported to promote the mass production of early-stage bone marrow-derived
mesenchymal stem cells (Park et al., 2013). Also, gelatin-coated beads were recently
used in the large scale expansion of Wharton’s jelly-derived mesenchymal stem cells
(Zhao et al., 2015).
One other possible interpretation is the young age of mice we used. Bergman et
al. previously reported that an increased proliferation rate was noticed in cultures of adult
mice than in those of young adults, later studies have given evidence that there is an
inverse relation between the age of mice and the proliferation pattern. Shi et al. looked at
adipose tissue-derived MSCs in juvenile and adult mice and found that cells isolated from
juveniles possess better attachment and proliferation than adults. These findings were
confirmed by another study published by Kretlow et al. in murine bone marrow-derived
MSCs. (Bergman et al., 1996; Shi et al., 2005; Kretlow et al., 2008).
The growth media used throughout the experiments could be another contributory
factor. The media utilized throughout our culture experiments was low serum media
(1%) supplemented with N2 growth supplement and several growth factors (GDNF, LIF
and b-FGF) to support the culture and expansion of tMSCs. There is a growing trend in
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research to substitute the conventional high serum-containing media with low or serumfree media to avoid the problems associated with using serum in MSC culture. Recent
studies have reported higher proliferation patterns and differentiation potencies in low
serum or serum free media when compared to serum containing media in culturing MSCs
derived from human dental pulp and adipose tissue (Ferro et al., 2012; Sato et al., 2015).
The use of growth supplements in cell culture media of MSCs is reported to
compensate for low serum content. Several studies have reported the establishment of
successful cultures in low serum media containing N2 and B27 supplements to support
the growth of dental pulp and skin-derived stem cells, respectively (Riekstina et al.,
2008; Bonnamain et al., 2013). Also, the use of growth factors has been studied in
enhancing the proliferation and self renewal capacities of MSCs. GDNF and b-FGF were
already reported in culturing human testis-derived MSCs and b-FGF was found
associated with high proliferation capacities of testis-derived multipotent stromal cells
isolated from the marmoset monkey (Gonzalez et al., 2009; Eildermann et al., 2012).
Leukemia Inhibitory Factor is conventionally used in culturing ESCs, it is postulated to
have roles in maintaining the self renewal state and preventing the differentiation of
ESCs (Furue et al., 2005). Also, LIF has been previously used with other growth factors
in culturing Multipotent Adult Progenitor Cells (Jiang et al., 2002b).
We could not follow through the cultures, due to experimental limitations, to
determine at what passage the cells cease to grow. However, the change in morphology
observed with later passages (starting from passage 6) together with the significant
increase in PDT at passage 7 suggests that the cells started entering a senescent or
stationary phase of proliferation. The morphological changes occurred are typical of the
Hayflick model of cellular aging. Also, they fall in line with previous studies on aged
MSCs reporting changes in cell shape and size, the nucleus becomes circumscribed with
granulated cytoplasm and increased cell debris (Bonab et al., 2006; Wagner et al.,
2008). The time at which senescence occurs, varies among different reports; some studies
report that senescence starts with later passages like passage 10 and passage 15 in UCMSCs and Wharton's Jelly-derived MSCs, respectively (Christodoulou et al., 2013;
Otte et al., 2013). However, several studies reported results similar to ours; adipose
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tissue-derived MCSs and BM-MSCs were found to show signs of senescence and a
marked increase in PDT at passage 6 (Lu et al., 2006; Christodoulou et al., 2013). In
addition, a study focused on the molecular events lying behind replicative senescence in
BM-MSCs and reported that senescence occurs starting from the 7th to the 12th passage
(Wagner et al., 2008).
4.3. tMSCs show surface marker profile characteristic of MSCs
Our results show that tMSCs express surface antigens of MSCs. At the transcript
level, tMSCs are CD29+, CD44+, CD73+ and CD45-. Phenotypic analysis for CD44 and
CD45 confirmed these results. We chose CD44, Cd73 and CD29 because they are
markers known to be consistently expressed among different murine MSCs isolated from
different sources like bone marrow, synovium, adipose tissue, epiphysis and many others
(Shen et al., 2011; Viero Nora et al., 2011; Cheng et al., 2012; Futami et al., 2012). In
fact, our surface marker profile falls in line with that of monkey testis-derived stem cells
which was found to be positive for CD29, CD44, CD49f, CD73, CD90, and CD105 while
negative for CD31, CD34, CD45, CD117 and CD133 (Eildermann et al., 2012).
We investigated the expression of MSCs surface markers in the initiating
population that is the testicular cell suspension to compare it with tMSCs and see whether
these markers are specific for tMSCs or expressed by other cell types. CD73 was found
not to be specific for tMSCs since its transcript levels showed high expression in the
testis. In fact, in 2010, a study was performed to investigate the expression of CD73 in
the murine reproductive system and reported that the protein was detected in germ cells
but not in spermatozoa and in somatic cells: Sertoli cells, peritubular, interstitial cells,
macrophages and Leydig cells (Martín-Satué et al., 2010). The high transcript levels for
CD29 (β1-integrin) in the testis revealed that it may not be considered specific for testisderived MSCs, previous studies revealed that CD29 was expressed in spermatogenic
cells; spermatocytes, spermatids, testicular spermatozoa and spermatogonial stem cells
(Schaller et al., 1993; Shinohara et al., 1999).
Transcript levels, confirmed by phenotypic analysis data, revealed the specifity of
CD44 to tMSCs, since it was found significantly higher in tMSCs than in testis. These
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data suggest that a small population of testicular cell types expresses CD44 marker and
that the enrichment process was successful since this small population of cells was
isolated and propagated to yield high expression levels from passage 0. Also, This
finding suggests the possible use of CD44 as a specific marker to isolate testis-derived
MSCs. FACS data revealed that a high percentage of cells expressed the marker, but it
was not above 90%. This could be attributed to the fact that FACS analysis was
performed in early passages (P1 and P2). Although this stage of culture should have
reached a high level of homogeneity, they have not “suffered” from an over-long
permanence in culture. However, testis-derived multipotent stromal cells isolated from
the monkey showed similar expression pattern where 62%-94% of the cells expressed
CD44 (Eildermann et al., 2012). Also, 78% of adipose tissue-derived MSCs at passage 2
were reported to express CD44 (Pascucci et al., 2011).
As for CD45, the lack of expression in tMSCs was expected since MSCs are
known not to express hematopoietic cell markers. The elevated expression in testis
compared to tMSCs suggested that there are cell types in the testis, other than tMSCs,
which express this marker and these cell types do not contribute to the adherent
monolayer. Also, the slight expression of CD45 in passage 0 suggests the presence of a
small percentage of these cell types which were filtered out with later passages. Although
both data from RT-PCR and FACS confirm the higher expression of CD45 in the testis
when compared to tMSCs, the percentage of CD45 in the testis was much lower at the
protein levels rather than the RNA. This might be explained by the presence of over 9
transcript variants for mouse CD45 detected by the used primers but only three encode
for proteins. Therefore, it is possible that there are certain non-coding variants expressed
but not detected at the protein level. The low protein levels of CD45 in the testis could be
further supported by the findings of Mullen TE where cells expressing CD45 were rarely
found in the testicular interstitium. Also, CD45 was found to be expressed by testicular
macrophages which represent only 12% of the interstitial cells of the testis (Dirami et al.,
1991; Habasque et al., 2002; Mullen Jr et al., 2003).
Next, we aimed to investigate the effect of serial passaging on the expression of
mesenchymal stem cell markers. Our results indicate that CD44 expression is not affected
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with passaging. However, CD73 and CD29 expression is down regulated with aging of
cells especially at passage 6 which appears to be in consonance with morphological and
growth kinetics data. Reports have shown contradicting data regarding which markers are
affected by senescence. In a study conducted by Zhaung Y comparing early (P3) and late
(P15) passages of umbilical cord-derived MSCs (UC-MSCs), it was concluded that aging
does not influence the expression of the tested MSC markers including CD44, CD73 and
CD29. On the contrary, Wagner W et al. found that early passages (P3) of bone marrowderived MSCs express much higher levels of MSCs markers than late passages (P12)
which also included CD44, CD73 and CD29. However, our data might be in line with
data of Cheng C et al. where it was found that the expression of some markers decrease
with senescence such as CD73, CD166 and Sca-1, while other markers maintain constant
levels of expression like CD44, CD29 and CD105. Also, It is possible that CD44 is
affected by passaging at later stages and not from the start of senescence. (Wagner et al.,
2008; Cheng et al., 2012; Zhuang et al., 2015). Collectively, our data suggest that
tMSCs started to undergo a stage of cellular senescence at passage 6 and this stage
affected the expression of some MSC markers like CD73 and CD29. For this reason, we
classified tMSCs into early and late stages to distinguish the phase at which cells start to
age.
4.4.tMSCs are not of germ cell origin
VASA is known to be a specific marker for germ cells in both humans and mouse
(Castrillon et al., 2000; Tanaka et al., 2000). Our data on the lack of expression of Vasa
in tMSCs fall in line with previously published data on testis-derived MSCs isolated from
the human and marmoset monkey. In fact, these reports postulate that testis-derived
MSCs originate from the interstitial stoma of the testis and they do not represent any of
the testis specific cell types, i.e.; Leydig, Sertoli, Myoid and germ cells (Eildermann et
al., 2012; Chikhovskaya et al., 2013). It is worth mentioning that the lack of expression
of germ cell marker further proves the homogeneity of the propagated population from
early passages and the good enrichment for MSCs cells.
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4.5.Expression of pluripotency markers
MSCs represent a source of adult stem cells endowed with a long-lasting but
finite proliferation potential, and they can differentiate toward multiple mesodermal
lineages. Researchers attempt to investigate the expression of pluripotency markers in
MSCs and see whether they govern their unique properties or not. In our study, tMSCs
showed positive expression of Nanog. However, they lack the expression of Oct4 which
contradict previous reports on the expression of Oct4 and its functional role in
maintaining MSC properties (Izadpanah et al., 2006; Tsai et al., 2012). Also, Gonzalez
et al. reported that human testis-derived MSCs express NANOG, OCT4 and SSEA4.
None the less, our data support previously published reports indicating that MSCs
isolated from the bone marrow, adipose tissue and cardiac tissue were found to express
NANOG but not OCT4 nor SOX2 (Pierantozzi et al., 2010). Also, Lengner CJ reported
in a study conducted on stem cells isolated from several somatic tissues that Oct4 is
dispensable for both self-renewal and maintenance of somatic stem cells in the adult
mammal (Lengner et al., 2007).
Mouse NANOG is a protein involved in the self renewal and maintenance of the
undifferentiated state of MSCs, it has 4 different alternatively spliced variants (variants 1,
2, 3 and 4) and 3 different isoforms (1, 2 and 3) where variants 3 and 4 encode for
isoform 3. Our data suggest that tMSCs, unlike the testis, express low levels of Nanog
variant 2. A high expression was noticed at the 583 bp band and it was low in the testis.
However, this band can detect variants 1, 3 and 4. Therefore we couldn’t determine
which of these variant(s) contributes to the pattern observed. There are few reports on the
expression patterns of different Nanog variants. Das et al. conducted several studies on
NANOG splice variants in human and mouse ESCs and reported the observed variation
in expression ratios of different transcripts. (Das et al., 2011; Das et al., 2012). Another
study reported the identification of a new variant of human NANOG which is highly
expressed in multipotent adult progenitor cells (MAPC). The variation was found
between the homeodomain and the tryptophan repeat (WR) regions of the full length
sequence. However, this variant had similar activity to the full length one (Kim et al.,
2005). It is possible that the variant(s) at 583 bp play a role in regulating the properties of
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tMSCs unlike variant 2. Also, the high expression of variant 2 in testicular cell population
suggests that there are cell types, other than tMSCs which express variant 2 more than the
remaining variants.
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5. Conclusions and Future Recommendations
5.1.Conclusions
Up to our knowledge, this is the first study to report the isolation of mesenchymal
stromal cells from the mouse testis. In our study, we describe a simple and rapid lamininbased technique to enrich for MSCs. The isolated cells were successfully cultured in vitro
and displayed morphological properties and marker profiles similar the ones reported for
MSCs.
The high yield of cells isolated and the high proliferation pattern in early passages
might suggest that the cells can be expanded to therapeutically necessary levels.
Examining the changes in morphology, PDT and expression pattern of MSC markers
allowed us to pinpoint at what stage the cells enter senescence. This is the first study to
report the variation in expression of Nanog variants in tMSCs. This finding sheds the
light on the possible use Nanog variants as specific markers for MSCs.
5.2.Future Recommendations
The scope of research that can be done to complement this study is huge. In fact,
this study is only the start of many experiments to be conducted on a promising cell type.
Multipotency is a golden criterion for MSCs, inducing the differentiation of tMSCs to
adipocytes, osteoblasts and chondrocytes is crucial to assess their stemness. Also,
immunophenotyping needs be done on other markers to confirm our data and compare
the marker profile of tMSCs with those of other testis-derived MSCs reported in the
literature. Senescence can be thoroughly studied in late passages through the assessment
of senescence-associated β-galactosidase (SA-b-gal) expression. Experiments targeting
each Nanog variant alone will be useful to determine which of the three variants (1, 3 or
4) contribute more, in terms of expression, to tMSCs. Also, extrapolating the lamininbased enrichment method to isolate MSCs from other sources will be useful to ensure the
reproducibility of this technique. In addition, in vivo studies using animal disease models
can be done to assess the therapeutic potential of tMSCs.
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